HURA
TuHURA Biosciences, Inc. NASDAQ Listed Feb 22, 2013$2.64
-2.58%
vs $2.71
Mkt Cap $126.5M
52w Low $0.44
78.3% of range
52w High $3.25
50d MA $2.41
200d MA $1.87
P/E (TTM)
-4.3x
EV/EBITDA
—
P/B
6.0x
Debt/Equity
0.0x
ROE
-143.6%
P/FCF
-4.6x
RSI (14)
66.20
ATR (14)
$0.19
Beta
-0.32
50d MA
$2.41
200d MA
$1.87
Avg Volume
538.6K
TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL.
10500 University Center Drive · Tampa, FL 33612 · US
Data updated apr 25, 2026 2:23pm
· Source: financialmodelingprep.com